Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice
Aida et al. Genome Biology
Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice
Tomomi Aida 1
Keiho Chiyo 1
Takako Usami
Harumi Ishikubo 1
Risa Imahashi 1
Yusaku Wada
Kenji F Tanaka
Tetsushi Sakuma
Takashi Yamamoto
Kohichi Tanaka 0 1
0 The Center for Brain Integration Research (CBIR), TMDU , Tokyo 113-8510 , Japan
1 Laboratory of Molecular Neuroscience, Medical Research Institute (MRI), Tokyo Medical and Dental University (TMDU) , Tokyo 113-8510 , Japan
Although the CRISPR/Cas system has enabled one-step generation of knockout mice, low success rates of cassette knock-in limit its application range. Here we show that cloning-free, direct nuclear delivery of Cas9 protein complex with chemically synthesized dual RNAs enables highly efficient target digestion, leading to generation of knock-in mice carrying a functional cassette with up to 50% efficiency, compared with just 10% by a commonly used method consisting of Cas9 mRNA and single guide RNA. Our cloning-free CRISPR/Cas system facilitates rapid one-step generation of cassette knock-in mice, accelerating functional genomic research by providing various in vivo genetic tools.
-
Background
Although gene-targeted knockout and knock-in mice are
invaluable tools for understanding the functions of genes
in vivo, the production of such genetically modified mice
has relied on gene targeting in embryonic stem cells,
which is a complicated and time-consuming process [1].
The recent development of the clustered regularly
interspaced short palindromic repeat (CRISPR)/CRISPR-associated
protein (Cas) system, a genome editing technology, has
allowed for the direct manipulation of the genome in
mouse zygotes in vivo (in vivo genome editing) with
extremely high efficiency, enabling the highly convenient
and ultra-rapid one-step generation of genetically
modified mice without embryonic stem cells [2,3].
A flood of studies using CRISPR/Cas-mediated in vivo
genome editing have reported the production of
knockout mice [4-6] and knock-in mice carrying single
nucleotide substitutions combined with oligo DNA donors
[5,7,8]. In contrast, there has been only one report on
the successful production of knock-in mice carrying
reporter gene cassettes [9], essential tools for analyzing
complex tissues such as brain in vivo [10], and the
efficacy of the targeted insertion of the reporter gene was
only about 10% [2,3,9,11]. The low success rates of gene
cassette knock-in limit the applicability of
CRISPR/Casmediated in vivo genome editing.
The CRISPR/Cas system was initially reported as an
adaptive immune system in bacteria, consisting of three
components including Cas9 nuclease and two small
RNAs, CRISPR RNA (crRNA), which guides the Cas9
complex to the target sequence, and trans-activating
crRNA (tracrRNA), which binds to crRNA and forms a
ribonucleoprotein complex with Cas9 nuclease [12].
When it was harnessed as a genome editing tool [13,14],
the dual-crRNA:tracrRNA was engineered as a chimeric
single guide RNA (sgRNA) [13]. The CRISPR/Cas
system consisting of two components - Cas9 nuclease and
sgRNA - is the most common approach in the field of
genome editing due to its enhanced convenience and
robust targeting [15]. However, it is still unknown whether
the commonly used sgRNA works more efficiently than
the dual-crRNA:tracrRNA, especially for the production
of knock-in mice carrying reporter gene cassettes.
Here, we show the highly efficient generation of
knockin mice carrying a functional gene cassette by a
cloningfree CRISPR/Cas system using Cas9 protein combined
with chemically synthesized dual-crRNA:tracrRNA.
Results
Generation of highly active guide sequence
In a previous study, we demonstrated that the insertion
of a transgene downstream of the Actb polyadenylation
signal allowed for sufficiently high levels of gene
induction [16,17]. Thus, we chose the Actb locus as a model
to be targeted for the generation of knock-in mice
carrying a functional gene cassette. We first designed the
guide sequence targeted to the locus 800 bp downstream
of the mouse Actb polyA signal (Figure 1a) and inserted
it into a bi-cistronic expression vector pX330 plasmid
[18,19] containing sequences encoding Cas9 and sgRNA
backbone sequences. Then, we determined its high
activity of DNA digestion in vitro using a single-strand
annealing (SSA) assay with episomal plasmid vectors
containing a split luciferase gene and Actb target
sequences in human HEK293T cell lines (Figure S1 in
Additional file 1), and a Cel-I assay in mouse Neuro2A
cell lines to target the endogenous mouse chromosome
(Figure S2 in Additional file 1).
To further test the activity of Actb sgRNA in vivo, we
injected Cas9 mRNA with Actb sgRNA - both in vitro
transcribed with T7 RNA polymerase using PCR
templates amplified from an Actb pX330 plasmid [11]
into one-cell stage mouse zygotes. We obtained 12
newborn mice and found that almost all the newborns
Figure 1 Generation of knock-in mice carrying gene cassette by sgRNA combined with Cas9 mRNA injection. (a) Targeting strategy for the generation
of Actb-TetO-FLEX-EGFP-polyA knock-in mice. (b) Schematic diagram of pronuclear injection of Cas9 mRNA, Actb sgRNA and TetO-FLEX-EGFP targeting
vector. (c) PCR screening of knock-in newborns derived from pronuclear RNA injection. (d) Sequences of boundaries between Actb and
TetO-FLEXEGFP-polyA cassette. IF, internal forward primer; IR, internal reverse primer; KI, knock-in; LF, left forward primer; LR, left reverse primer; RF, right forward
primer; RR, right reverse primer; L-HA, left homology arm; R-HA, right homology arm; M, molecular marker; WT, wild type.
were bi-allelically targeted mutants (Figure S3 and
Table S1 in Additional file 1). Thus, the Actb sgRNA we
designed is highly active both in vitro and in vivo for
target digestion and subsequent induction of
nonhomologous end-joining (NHEJ).
Generation of reporter knock-in mice by sgRNA combined
with Cas9 mRNA
As a model for knock-in mice carrying a functional gene
cassette, we designed reporter mice highly expressing
enhanced green fluorescent protein (EGFP) from the
endogenous Actb locus only in a specific cell population
intersectionally defined [20] by the expression of Cre
recombinase and tetracycline transactivator (tTA). We
constructed a 10.5 kb targeting vector for the mouse
Actb locus containing a 2.5 kb TetO-FLEX-EGFP-polyA
cassette (Tet operator (tetO) sequence concatemers
fused to a minimal cytomegalovirus (CMV) promoter,
beta-globin intron, inverted EGFP flanked by two pairs
of loxP and lox2722 (FLEX switch) and polyA), and
2.0 kb left and right homology arms of the Actb locus
(Actb-TetO-FLEX-EGFP-polyA; Figure 1a).
Next, we injected the circular
Actb-TetO-FLEX-EGFPpolyA targeting vector together with Actb sgRNA and
Cas9 mRNA, both in vitro transcribed as above, into
one-cell-stage mouse zygotes (Figure 1b). We injected
the mixture (5 ng/l Cas9 mRNA, 2.5 ng/l Actb
sgRNA, and 10 ng/l of the targeting (...truncated)